U.S. Paper and Forestry Products Stock News

Senseonics Holdings went into this report as a high growth, high expectation diabetes tech stock, and the market clearly liked what it saw. The share price jumped about 36% to US$7.02 the day after earnings, a big move for a medical device company still posting sizeable losses. The headline is simple: strong revenue traction in continuous glucose monitoring and a sharp lift in gross margin grabbed investors’ attention, even though Senseonics reported a net loss of US$36.7 million for the...

Brookfield Infrastructure Partners (NYSE:BIP) reported second quarter 2026 results with sales of US$6,482 million and a net loss of US$24 million, along with an affirmed quarterly distribution of US$0.455 per unit. See our latest analysis for Brookfield Infrastructure Partners. At a share price of US$39.04, Brookfield Infrastructure Partners has seen a 4.5% 1 month share price return and a 13.8% share price return year to date. The 1 year total shareholder return of 36.2% points to stronger...

Cactus has delivered a 104.5% return over the past five years, yet its current checks send mixed valuation signals, with the Discounted Cash Flow (DCF) estimate pointing to upside while earnings-based multiples point to a richer price tag. The 104.5% five year return sets a high bar for new buyers and raises the question of how much future performance is already reflected in the share price. Recent earnings strength can support higher expectations for cash generation, although any pressure...

ACM Research earnings jump puts profitability in focus ACM Research (ACMR) is back in the spotlight after reporting second quarter 2026 results, with sales of US$292.92 million and net income of US$88.98 million, both higher than a year earlier. See our latest analysis for ACM Research. At a latest share price of US$83.80, ACM Research has seen a 6.1% 1 day share price return and a 40.0% 90 day share price return, while the 1 year total shareholder return is very large and indicates strong...

In the second quarter of 2026, Mirum Pharmaceuticals reported a net loss of US$67.23 million, or US$1.06 per share, and for the first half of 2026 its net loss widened to a very large US$857.38 million, or US$14.03 per share, even as it raised full-year 2026 product sales guidance to US$680 million–US$700 million on stronger-than-expected revenue including US$176 million in second-quarter sales. An important nuance for investors is that while LIVMARLI’s US$129 million in quarterly sales and...

Rapid money growth and fresh support from the Federal Reserve are flooding markets with liquidity, even as high policy rates remain in place. That mix can reward some large U.S. growth stocks and leave others exposed if conditions shift. This article walks through how those cross currents connect to three specific stocks from a U.S. Large Cap Growth Stocks screener, and why their exposure to these policy moves matters for your portfolio decisions today. The stocks covered below are just a...

In early August 2026, Trupanion reported second-quarter results showing net income of US$6.83 million, earnings per share of US$0.16, and issued updated guidance pointing to third-quarter revenue of about US$399 million to US$405 million and full-year 2026 revenue of roughly US$1.58 billion to US$1.60 billion. Alongside this financial update, Trupanion unveiled a US$100 million share repurchase program and an integration with veterinary software provider Digitail, highlighting a focus on...

NeoGenomics earnings shift puts Q2 profitability in focus NeoGenomics (NEO) returned to profitability in the second quarter of 2026, reporting net income of US$2.24 million on sales of US$201.66 million, compared with a net loss a year earlier. See our latest analysis for NeoGenomics. At a share price of US$16.57, NeoGenomics has seen strong momentum build over 2026, with a 90 day share price return of 84.93% and a 1 year total shareholder return of 185.69%. This reflects shifting...

Open Text came into this earnings print with a stock that had quietly climbed over the past month, then gave back ground as shares fell about 3% in the first session after results. The long term thesis centers on a cash generative software platform that pays investors a dividend and trades on a single digit P/E. The headline from this quarter is profit strength. Adjusted EBITDA margin sat in the mid 30s, free cash flow reached about US$808m for the year and net margin over the last twelve...

CRA International stock gave back 4.1% the day after posting what management called record second quarter results. That gap between a softer share price and stronger reported fundamentals is the story investors need to unpack. CRA International booked revenue of US$210.8m for Q2, the highest quarterly level in its history, with basic earnings per share of US$2.13. The company also flagged record first half non GAAP earnings before interest, tax, depreciation and amortization. The full picture...

nCino has had a difficult run for shareholders over the past five years, yet recent product news around its Mortgage MCP platform sits against a valuation picture that screens as somewhat expensive on market multiples and only mixed on broader checks. The share price is down 69.0% over the past five years, which puts extra pressure on any case that the current valuation leaves room for recovery. The launch of Mortgage MCP, which connects AI agents directly to the nCino Mortgage Suite, can...

Beyond Meat (BYND) is back in the spotlight after reporting second quarter 2026 results that swung to a net profit, alongside fresh revenue guidance and new leadership moves at both the executive and board level. See our latest analysis for Beyond Meat. Despite the switch back to profitability, Beyond Meat’s 1 year total shareholder return is down 79.79% and the share price is down 38.99% year to date. A 90 day share price decline of 35.46% highlights that recent earnings and leadership...

Why Intuitive Surgical’s governance changes matter for shareholders Intuitive Surgical (ISRG) recently updated its bylaws to align with U.S. universal proxy rules and tighten procedures around shareholder nominations, proposals, and special meetings. These governance adjustments now sit alongside interest in the da Vinci 5 rollout. See our latest analysis for Intuitive Surgical. Against this backdrop, Intuitive Surgical’s recent share price has been volatile, with the stock up 7.21% over the...

Earlier this week, Gilead Sciences reported second-quarter 2026 results showing revenue of US$7.80 billion but a net loss of US$10.50 billion, cut its full-year earnings outlook, affirmed a US$0.82 quarterly dividend, and filed an omnibus shelf registration covering multiple security types. The sharp swing from profit to loss, alongside guidance for higher full‑year operating losses, raises fresh questions about how Gilead balances investment, capital returns, and future financing...

In August 2026, Healthpeak Properties, Inc. reported past second-quarter 2026 results showing revenue of US$771.58 million and net income of US$52.82 million, alongside higher first-half earnings per share from continuing operations compared with a year earlier. On the same day, the company also raised its full-year 2026 diluted earnings guidance to a range of US$0.48 to US$0.52 per share, signaling management confidence after stronger year-to-date performance. Next, we’ll examine how...

Why CoStar Group’s Latest Quarter Caught Investor Attention CoStar Group (CSGP) drew fresh investor focus after reporting second quarter 2026 results, issuing updated guidance and sharing new multifamily and office market data that together reshaped expectations for its real estate information business. See our latest analysis for CoStar Group. At a share price of $30.24, CoStar Group has seen a 1-day share price return of 2.23% and a 7-day share price return of 5.15%, yet its year to date...

Chesapeake Utilities stock barely moved after earnings, up just 0.3% to about US$133.85, even as the company put a very big number on the table. The real headline is not the modest 1% adjusted EPS growth to roughly US$1.05 this quarter. It is the decision to lean into a huge new US$1.2b transmission project that will reshape the balance between growth ambition, capital intensity and investor patience. With trailing earnings still healthy and the P/E sitting above both peer and industry...

Plug Power (PLUG) is back in focus as investors look ahead to the June quarter earnings report on August 10, 2026, with expectations for a smaller loss and softer revenue. See our latest analysis for Plug Power. Against this backdrop of earnings expectations and project wins, Plug Power’s share price has been volatile, with a 1-day share price return of 5.31% and a 7-day share price return of 5.83% after a 90-day share price decline of 30.13%. The 1-year total shareholder return of 44.37%...

With long term unemployment falling for worrying reasons and labor force participation back to early 2021 levels, the job market looks stronger on the surface than it really is. Healthcare is one of the few areas still adding jobs, which can concentrate both risk and opportunity. This article walks through 3 healthcare sector stocks from the screener that are closely tied to this jobs story and explains why they may deserve a closer look. The stocks covered below are just a small sample from...

Telephone and Data Systems (TDS) reported Q2 2026 results that included sales of US$53.18 million, revenue of US$309.28 million, and net income of US$298.37 million, all higher than the prior year period. See our latest analysis for Telephone and Data Systems. The strong Q2 figures arrived after a tough stretch for Telephone and Data Systems shareholders, with the stock down 29.03% on a 90 day share price return and the 1 year total shareholder return still up 87.34% over five years, which...

Kingstone Companies stock just gave back 8.5% in a single session, even as the insurer posted what management called the most profitable quarter in its history. The market is trading the headline price drop. The earnings print centers on a different headline, a 70.2% combined ratio and US$15.5m in net income that indicate significant underwriting profitability for a regional carrier of this size. Coming into today, Kingstone had already logged a strong 90 day run. The key issue now is whether...

After a weak July jobs report showed the U.S. economy losing 23,000 positions and easing pressure on the Federal Reserve to lift rates further, dividend growth stocks suddenly look more interesting to investors hunting for reliable income and potential stability. Lower yields have helped push major indexes to record levels, and that can create a fear of missing out. This article walks through three dividend growth stocks exposed to this shifting rate story and explains how the recent news...

Dentsply Sirona walked into this quarter with a turnaround label and a cheap stock narrative. The share price dropped 8% to about US$12 after the release, yet the headline from the numbers is quieter and more mixed than that move suggests. Revenue came in at US$898m and adjusted earnings per share held at US$0.52, helped by a one off tariff refund. For a company still carrying losses on a trailing twelve month basis, this update was less about a clean reset and more about whether the early...

Cheniere Energy Partners just delivered one of those quarters that makes the share price move look out of step with the story. The stock is down about 1.8% since the earnings release, yet Q2 landed with US$2.40 in basic earnings per unit on US$2.58b of revenue and a trailing P/E sitting around 10.8x. For an LNG export partnership often viewed as a mature, yield focused vehicle with balance sheet questions, the headline this quarter is simple: profitability remains solid while the valuation...